Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0028Subject Initials :XHLDOB :04/12/1981Sex:FemaleRace:AsianHeight:158cmWeight:65.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/12/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/28/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Left abdominal ectopic pregnancy salpingectomyUk-Unk-2002Not on treatment/medication
Right next laparoscopic tubal ectopic pregnancy surgeryUk-Unk-2010Not on treatment/medication
Conservative treatment of ectopic pregnancyUk-Unk-2004Not on treatment/medication
Conservative treatment of ectopic pregnancyUk-Unk-2005Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0028
Page 1 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0045Subject Initials :H-TDOB :09/08/1983Sex:FemaleRace:AsianHeight:158cmWeight:57.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015250
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopic polypectomyUk-Aug-2014Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0045
Page 2 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0060Subject Initials :Y-WDOB :11/10/1981Sex:FemaleRace:AsianHeight:150cmWeight:45.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/30/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic pelvic sticking points, ovarian drilling, tubal surgery to clear.Uk-Unk-2014Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0060
Page 3 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0061Subject Initials :T-DDOB :02/15/1988Sex:FemaleRace:AsianHeight:161cmWeight:60.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
salpingemphraxis,laparoscopic operationUk-Unk-2014Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0061
Page 4 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0063Subject Initials :HMCDOB :07/25/1981Sex:FemaleRace:AsianHeight:162cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/15/2015250
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/01/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopic surgery through liquidUk-Unk-2014Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0063
Page 5 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0076Subject Initials :F-LDOB :05/15/1987Sex:FemaleRace:AsianHeight:150cmWeight:51.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/15/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/30/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Sticky points lower pelvic laparoscopy surgery, tubal surgery.Uk-Unk-2012Not on treatment/medication
Hysteroscopic tubal surgeryUk-Sep-2014Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0076
Page 6 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0082Subject Initials :Y-LDOB :09/04/1986Sex:FemaleRace:AsianHeight:162cmWeight:59.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/02/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



01-AUG-16
NA/EMR700623-541/C02-0082
Page 7 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0083Subject Initials :Y-LDOB :08/20/1988Sex:FemaleRace:AsianHeight:158cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/03/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic pelvic sticky points left salpingostomyUk-Unk-2013Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0083
Page 8 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0086Subject Initials :YZZDOB :07/07/1987Sex:FemaleRace:AsianHeight:150cmWeight:55.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/04/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



01-AUG-16
NA/EMR700623-541/C02-0086
Page 9 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0088Subject Initials :HLKDOB :06/14/1986Sex:FemaleRace:AsianHeight:159cmWeight:59.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/02/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Palace laparoscopic pelvic surgery sticky points, bilateral tubal plastic surgery, endometriosis lesions fulguration.Uk-Unk-2012Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0088
Page 10 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0089Subject Initials :XYZDOB :06/12/1986Sex:FemaleRace:AsianHeight:152cmWeight:48.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015187.5
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/07/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Sticky points pelvic laparoscopy surgery, tubal surgery to clearUk-Nov-2012Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0089
Page 11 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0095Subject Initials :MLGDOB :08/19/1990Sex:FemaleRace:AsianHeight:155cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/19/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/03/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



01-AUG-16
NA/EMR700623-541/C02-0095
Page 12 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0102Subject Initials :HYDDOB :10/14/1985Sex:FemaleRace:AsianHeight:163cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/19/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/04/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Palace laparoscopy Uk-Unk-2013Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0102
Page 13 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0111Subject Initials :CXWDOB :10/10/1979Sex:FemaleRace:AsianHeight:162cmWeight:68.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/20/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/05/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy laparoscopic surgery, the left fallopian tube embryo window.Uk-Unk-2012Not on treatment/medication
Tubal lipiodol angiographyUk-Unk-2013Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0111
Page 14 of36
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-07-31 End Date:2016-08-01
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0115Subject Initials :KJTDOB :07/02/1988Sex:FemaleRace:AsianHeight:163cmWeight:52.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/21/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/05/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG examination: bilateral tubal occlusionUk-Unk-2012Not on treatment/medication
Laparoscopy surgery: pelvic sticky points, bilateral tubal ostomy + right side mesosalpinx cyst removal.Uk-May-2015Not on treatment/medication



01-AUG-16
NA/EMR700623-541/C02-0115
Page 15 of36